Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
Author(s) -
Bianca Itariu,
Maximilian Zeyda,
Eva Hochbrugger,
Angelika Neuhofer,
Gerhard Prager,
Karin Schindler,
Arthur Bohdjalian,
Daniel Mascher,
Suman Vangala,
M. Eric Schranz,
Michael Krebs,
Martin Bischof,
Thomas M. Stulnig
Publication year - 2012
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.112.037432
Subject(s) - adipose tissue , medicine , endocrinology , inflammation , polyunsaturated fatty acid , systemic inflammation , biology , fatty acid , biochemistry
Chronic adipose tissue inflammation is a hallmark of obesity, triggering the development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs reduce cardiovascular events and exert well-established antiinflammatory effects, but their effects on human adipose tissue inflammation are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom